Irbesartan in patients with atrial fibrillation

The ACTIVE I Investigators

doi:10.1056/NEJMoa1008816

Irbesartan in patients with atrial fibrillation

The ACTIVE I Investigators

Research output: Contribution to journal › Article › peer-review

213 Citations (Scopus)

Abstract

Irbesartan did not reduce cardiovascular events in patients with atrial fibrillation. (Funded by Bristol-Myers Squibb and Sanofi-Aventis; ClinicalTrials.gov number, NCT00249795.).

Original language	English
Pages (from-to)	928-938
Number of pages	11
Journal	New England Journal of Medicine
Volume	364
Issue number	10
DOIs	https://doi.org/10.1056/NEJMoa1008816
Publication status	Published - 2011

Access to Document

10.1056/NEJMoa1008816

Cite this

@article{94e859ad413b44e7a59982dbe466c535,

title = "Irbesartan in patients with atrial fibrillation",

abstract = "Irbesartan did not reduce cardiovascular events in patients with atrial fibrillation. (Funded by Bristol-Myers Squibb and Sanofi-Aventis; ClinicalTrials.gov number, NCT00249795.).",

author = "Salim Yusuf and Healey, {Jeff S.} and Janice Pogue and Susan Chrolavicius and Marcus Flather and Hart, {Robert G.} and Hohnloser, {Stefan H.} and Joyner, {Campbell D.} and Pfeffer, {Marc A.} and Connolly, {Stuart J.} and {The ACTIVE I Investigators}",

year = "2011",

doi = "10.1056/NEJMoa1008816",

language = "English",

volume = "364",

pages = "928--938",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachusetts Medical Society",

number = "10",

}

TY - JOUR

T1 - Irbesartan in patients with atrial fibrillation

AU - Yusuf, Salim

AU - Healey, Jeff S.

AU - Pogue, Janice

AU - Chrolavicius, Susan

AU - Flather, Marcus

AU - Hart, Robert G.

AU - Hohnloser, Stefan H.

AU - Joyner, Campbell D.

AU - Pfeffer, Marc A.

AU - Connolly, Stuart J.

AU - The ACTIVE I Investigators

PY - 2011

Y1 - 2011

N2 - Irbesartan did not reduce cardiovascular events in patients with atrial fibrillation. (Funded by Bristol-Myers Squibb and Sanofi-Aventis; ClinicalTrials.gov number, NCT00249795.).

AB - Irbesartan did not reduce cardiovascular events in patients with atrial fibrillation. (Funded by Bristol-Myers Squibb and Sanofi-Aventis; ClinicalTrials.gov number, NCT00249795.).

U2 - 10.1056/NEJMoa1008816

DO - 10.1056/NEJMoa1008816

M3 - Article

SN - 0028-4793

VL - 364

SP - 928

EP - 938

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 10

ER -